Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Livzon Pharmaceutical Group Inc

+ Add to Watchlist

000513:CH

58.180 CNY 0.390 0.67%

As of 03:00:25 ET on 03/27/2015.

Snapshot for Livzon Pharmaceutical Group Inc (000513)

Open: 58.150 Day's Range: 56.500 - 58.320 Volume: 2,302,388
Previous Close: 57.790 52wk Range: 40.200 - 59.100 1-Yr Rtn: +33.06%

Stock Chart for 000513

No chart data available.
  • 000513:CH 58.180
  • 1D
  • 1M
  • 1Y
57.790
Interactive 000513 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 000513

Current P/E Ratio (ttm) 33.3896
Estimated P/E(12/2015) 26.0546
Relative P/E vs. SZASHR 0.6860
Earnings Per Share (CNY) (ttm) 1.7425
Est. EPS (CNY) (12/2015) 2.2330
Est. PEG Ratio -
Market Cap (M CNY) 14,913.05
Shares Outstanding (M) 183.73
30 Day Average Volume 2,053,483
Price/Book (mrq) 4.6544
Price/Sale (ttm) 3.1425
Dividend Indicated Gross Yield 0.17%
Cash Dividend (CNY) 0.1000
Dividend Ex-Date
5 Year Dividend Growth 37.97%
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 000513

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 000513

Livzon Pharmaceutical Group Inc. develops and manufactures pharmaceutical products, including chemical medicines, bio-chemical medicines, biological engineering medicines, chemical compound crude medicines, antibiotics, micro-ecological preparations, patent Chinese medicines, and diagnosis reagents etc.

Tao DeshengPresidentYang DaihongVice President
Lu WenqiVice PresidentXu GuoxiangVice President
More Company Profile & Key Executives for 000513

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil